Tagitanlimab Combined with Sacituzumab Tirumotecan in Neoadjuvant Therapy for Locally Advanced Head and Neck Squamous Cell Carcinoma: A Single-Arm, Single-Center, Phase Ⅱ Clinical Trial (ChiCTR) - Oct 16, 2026 - P2 | N=30 | Not yet recruiting | Sponsor: The First Affiliated Hospital of Zhengzhou University; The First Affiliated Hospital of Zhengzhou University
New P2 trial • Head and Neck Cancer • Oncology • Solid Tumor • Squamous Cell Carcinoma of Head and Neck
|